1. Home
  2. Directory
  3. Nebraska
  4. Omaha
  5. Obstetrics Gynecology
  6. NPI Profile
  7. Prescriptions 1225242597

DR. SAMI KHALIL ZEINEDDINE M.D.
Prescription History 1225242597
Obstetrics & Gynecology - Hospice and Palliative Medicine in Omaha, NE

NPI Status: Active since May 09, 2007

Contact Information

6829 N 72ND ST
SUITE 4500
OMAHA, NE
ZIP 68122
Phone: (402) 572-3790
Fax: (402) 572-3779

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SAMI KHALIL ZEINEDDINE M.D., an active Hospice and Palliative Medicine specialist practicing in Omaha, NE. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 28 documented patient claims. Among these therapy options, the most frequently utilized medication is Tolterodine Tartrate Er, which accounts for 15 claims alone.

Medication Index

O
T
No matching medications currently found on file.

Oxybutynin Chloride Er

Generic Formulation: Oxybutynin ChlorideSpecialty: Obstetrics & Gynecology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
NE State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills52.8
Peer Average Days Supply1,528
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.6% less volume than the regional standard for practitioners inside NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$0.87

State Avg Cost Per Claim

$37.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (such as spina bifida).

Tolterodine Tartrate Er

Generic Formulation: Tolterodine TartrateSpecialty: Obstetrics & Gynecology
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.7
Days Supply 437
NE State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills22.1
Peer Average Days Supply620
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,064.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$204.28

State Avg Cost Per Claim

$141.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An ANTIMUSCARINIC AGENT selective for the MUSCARINIC RECEPTORS of the BLADDER that is used in the treatment of URINARY INCONTINENCE and URINARY URGE INCONTINENCE.

Therapeutic Applications

This medication is used to treat an overactive bladder. By relaxing the muscles in the bladder, tolterodine improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. SAMI KHALIL ZEINEDDINE M.D. provides transparency into local medical care patterns within Omaha, NE.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Hospice and Palliative Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.